CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

被引：441

作者：

Bradshaw, Elizabeth M. ^{[1
,2
,3
,4
]}

Chibnik, Lori B. ^{[1
,2
,3
,4
]}

Keenan, Brendan T. ^{[1
,2
,4
]}

Ottoboni, Linda ^{[1
,2
,3
,4
]}

Raj, Towfique ^{[1
,2
,3
,4
]}

Tang, Anna ^{[1
,2
,4
]}

Rosenkrantz, Laura L. ^{[1
,2
,4
]}

Imboywa, Selina ^{[1
,2
,4
]}

Lee, Michelle ^{[1
,2
]}

Von Korff, Alina ^{[1
,2
]}

Morris, Martha C. ^{[5
]}

Evans, Denis A. ^{[6
]}

Johnson, Keith ^{[3
,7
,9
]}

Sperling, Reisa A. ^{[3
,7
,8
,9
]}

Schneider, Julie A. ^{[5
]}

Bennett, David A. ^{[5
]}

De Jager, Philip L. ^{[1
,2
,3
,4
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

[4] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA

[5] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA

[6] Rush Univ, Med Ctr, Rush Inst Hlth Aging, Chicago, IL 60612 USA

[7] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA

[8] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimers Res & Treatment, Boston, MA 02115 USA

[9] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA

来源：

NATURE NEUROSCIENCE | 2013年 / 16卷 / 07期

基金：

美国国家卫生研究院;

关键词：

GENOME-WIDE ASSOCIATION; COGNITIVE IMPAIRMENT; IDENTIFIES VARIANTS; COMMON VARIANTS; EPHA1; PET; DEMENTIA; BINDING; CD2AP; BETA;

D O I：

10.1038/nn.3435

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

In our functional dissection of the CD33 Alzheimer's disease susceptibility locus, we found that the rs3865444(C) risk allele was associated with greater cell surface expression of CD33 in the monocytes ( t(50) = 10.06, P-joint = 1.3 x 10(-13)) of young and older individuals. It was also associated with diminished internalization of amyloid-beta 42 peptide, accumulation of neuritic amyloid pathology and fibrillar amyloid on in vivo imaging, and increased numbers of activated human microglia.

引用

页码：848 / U92

页数：5

共 41 条

[31] Principal components analysis corrects for stratification in genome-wide association studies
Price, Alkes L.
Patterson, Nick J.
Plenge, Robert M.
Weinblatt, Michael E.
Shadick, Nancy A.
Reich, David
[J]. NATURE GENETICS, 2006, 38 (08) : 904 - 909
[32] Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B
Price, JC
Klunk, WE
Lopresti, BJ
Lu, XL
Hoge, JA
Ziolko, SK
Holt, DP
Meltzer, CC
DeKosky, ST
Mathis, CA
[J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (11) : 1528 - 1547
[33] GenePattern 2.0
Reich, M
Liefeld, T
Gould, J
Lerner, J
Tamayo, P
Mesirov, JP
[J]. NATURE GENETICS, 2006, 38 (05) : 500 - 501
[34] A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Salloway, S.
Sperling, R.
Gilman, S.
Fox, N. C.
Blennow, K.
Raskind, M.
Sabbagh, M.
Honig, L. S.
Doody, R.
van Dyck, C. H.
Mulnard, R.
Barakos, J.
Gregg, K. M.
Liu, E.
Lieberburg, I.
Schenk, D.
Black, R.
Grundman, M.
[J]. NEUROLOGY, 2009, 73 (24) : 2061 - 2070
[35] Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology
Schneider, JA
Wilson, RS
Bienias, JL
Evans, DA
Bennett, DA
[J]. NEUROLOGY, 2004, 62 (07) : 1148 - 1155
[36] Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, Sudha
Fitzpatrick, Annette L.
Ikram, M. Arfan
DeStefano, Anita L.
Gudnason, Vilmundur
Boada, Merce
Bis, Joshua C.
Smith, Albert V.
Carassquillo, Minerva M.
Lambert, Jean Charles
Harold, Denise
Schrijvers, Elisabeth M. C.
Ramirez-Lorca, Reposo
Debette, Stephanie
Longstreth, W. T., Jr.
Janssens, A. Cecile J. W.
Pankratz, V. Shane
Dartigues, Jean Francois
Hollingworth, Paul
Aspelund, Thor
Hernandez, Isabel
Beiser, Alexa
Kuller, Lewis H.
Koudstaal, Peter J.
Dickson, Dennis W.
Tzourio, Christophe
Abraham, Richard
Antunez, Carmen
Du, Yangchun
Rotter, Jerome I.
Aulchenko, Yurii S.
Harris, Tamara B.
Petersen, Ronald C.
Berr, Claudine
Owen, Michael J.
Lopez-Arrieta, Jesus
Varadarajan, Badri N.
Becker, James T.
Rivadeneira, Fernando
Nalls, Michael A.
Graff-Radford, Neill R.
Campion, Dominique
Auerbach, Sanford
Rice, Kenneth
Hofman, Albert
Jonsson, Palmi V.
Schmidt, Helena
Lathrop, Mark
Mosley, Thomas H.
Au, Rhoda
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (18): : 1832 - 1840
[37] Testing the Right Target and Right Drug at the Right Stage
Sperling, Reisa A.
Jack, Clifford R., Jr.
Aisen, Paul S.
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (111)
[38] Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Sperling, Reisa A.
Aisen, Paul S.
Beckett, Laurel A.
Bennett, David A.
Craft, Suzanne
Fagan, Anne M.
Iwatsubo, Takeshi
Jack, Clifford R., Jr.
Kaye, Jeffrey
Montine, Thomas J.
Park, Denise C.
Reiman, Eric M.
Rowe, Christopher C.
Siemers, Eric
Stern, Yaakov
Yaffe, Kristine
Carrillo, Maria C.
Thies, Bill
Morrison-Bogorad, Marcelle
Wagster, Molly V.
Phelps, Creighton H.
[J]. ALZHEIMERS & DEMENTIA, 2011, 7 (03) : 280 - 292
[39] Wechsler D., 1987, Wechsler memory scale-revised
[40] Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Winblad, Bengt
Andreasen, Niels
Minthon, Lennart
Floesser, Annette
Imbert, Georges
Dumortier, Thomas
Maguire, R. Paul
Blennow, Kaj
Lundmark, Joens
Staufenbiel, Matthias
Orgogozo, Jean-Marc
Graf, Ana
[J]. LANCET NEUROLOGY, 2012, 11 (07) : 597 - 604

← 1 2 3 4 5 →